Sector ratings BioNTech SE

Stocks

Market Closed - Nasdaq Other stock markets 01:30:00 11/07/2026 am IST			5-day change	1st Jan Change
91.49 ^USD	-1.60%		-6.21%	-3.90%

10/07	Polish air traffic control faces funding freeze over COVID vaccine ruling	RE
08/07	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation
BIONTECH SE	2.31TCr	-	-	-		-
WUXI APPTEC CO., LTD.	5.49TCr		AAA
ARGENX SE	5.46TCr		A
INSMED INCORPORATED	2.51TCr	-	A	-		-
WUXI BIOLOGICS (CAYMAN) INC.	1.99TCr		AAA
GENMAB A/S	1.75TCr		A
PHARMAESSENTIA CORPORATION	1.65TCr		AA
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1.57TCr	-	AA	-		-
EXELIXIS, INC.	1.42TCr		BB
MADRIGAL PHARMACEUTICALS, INC.	1.24TCr	-	B	-		-
SUMMIT THERAPEUTICS INC.	1.18TCr	-	-	-		-
CYTOKINETICS, INCORPORATED	1.15TCr	-	AA	-		-
AKESO, INC.	1.14TCr		B
ARROWHEAD PHARMACEUTICALS, INC.	1.08TCr	-	BB	-		-
NUVALENT, INC.	982.96Cr	-	CCC	-		-
REMEGEN CO., LTD.	922.19Cr		-
CRINETICS PHARMACEUTICALS, INC.	881.27Cr	-	BBB	-		-
IMMUNITYBIO, INC.	860.92Cr	-	CCC	-		-
SPYRE THERAPEUTICS, INC.	859.49Cr	-	BB	-	-	-
VAXCYTE, INC.	840.54Cr	-	BBB	-		-
Average	1.76TCr		A
Weighted average by Cap.			A